令癌莎- Wikiwand
763113-22-0 Olaparib - Watson International Ltd
Targeting dePARylation selectively suppresses DNA repair–defective and PARP inhibitor–resistant malignancies | Science Advances
Olaparib CAS 763113-22-0 Watson International Limited
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Olaparib – Wikipedia
PARP inhibitor - Wikipedia
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
PharmaWiki - Olaparib
olaparib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
BRCA Support Liverpool
Olaparib: Cos'è, A Cosa Serve, Quando si Assume
PARP inhibitors: Synthetic lethality in the clinic | Science
ShopUi
Olaparib - Wikipedia, la enciclopedia libre
Olaparib - Wikipedia
Olaparib - Wikipedia
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
HemOnc.org | A Hematology Oncology Wiki
Olaparib - Wikipedia
![Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969805122020856-ga1.jpg "Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect")
Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
